Showing results (31-40 of 259) with videos related to

Sort By:
Pageof 26
Pharmaceutics|October 11, 2016
Induction of Drug Transporters Alters Disposition of Risperidone - A Study in MiceDavid Holthoewer, Christoph Hiemke, Ulrich Schmitt
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|June 2, 2006
Activation of muscarinic and nicotinic acetylcholine receptors in the nucleus accumbens core is necessary for the acquisition of drug reinforcementJose A Crespo, Katja Sturm, Alois Saria, et al.
Therapeutic Drug Monitoring|November 16, 2020
Therapeutic Drug Monitoring of Long-Acting Injectable Antipsychotic DrugsGeorgios Schoretsanitis, Pierre Baumann, Andreas Conca, et al.
The Journal of Clinical Psychiatry|July 20, 2023
Therapeutic Reference Range for Olanzapine in Schizophrenia: Systematic Review on Blood Concentrations, Clinical Effects, and Dopamine Receptor OccupancyKatja Wesner, Christoph Hiemke, Niels Bergemann, et al.
Fortschritte Der Neurologie-Psychiatrie|March 21, 2017
[Update Opipramol]Maximilian Gahr, Christoph Hiemke, Bernhard J Connemann
Current Pharmaceutical Design|June 12, 2012
Therapeutic drug monitoring for antidepressant drug treatmentElnaz Ostad Haji, Christoph Hiemke, Bruno Pfuhlmann
Frontiers in Psychiatry|March 3, 2020
Development of Obsessive-Compulsive Symptoms Following Abrupt Discontinuation of VenlafaxineMaximilian Gahr, Christoph Hiemke, Markus Alexander Kölle
The International Journal of Neuroscience|November 20, 2009
Rotarod impairment: catalepsy-like screening test for antipsychotic side effectsKatrin M Kirschbaum, Christoph Hiemke, Ulrich Schmitt
Expert Opinion on Drug Metabolism & Toxicology|February 16, 2016
Assessing drug-drug interactions through therapeutic drug monitoring when administering oral second-generation antipsychoticsEdoardo Spina, Christoph Hiemke, Jose de Leon
Pageof 26